Correlation Between Molecular Partners and Foghorn TherapeuticsInc
Can any of the company-specific risk be diversified away by investing in both Molecular Partners and Foghorn TherapeuticsInc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Molecular Partners and Foghorn TherapeuticsInc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Molecular Partners AG and Foghorn TherapeuticsInc, you can compare the effects of market volatilities on Molecular Partners and Foghorn TherapeuticsInc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Molecular Partners with a short position of Foghorn TherapeuticsInc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Molecular Partners and Foghorn TherapeuticsInc.
Diversification Opportunities for Molecular Partners and Foghorn TherapeuticsInc
-0.38 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Molecular and Foghorn is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding Molecular Partners AG and Foghorn TherapeuticsInc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Foghorn TherapeuticsInc and Molecular Partners is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Molecular Partners AG are associated (or correlated) with Foghorn TherapeuticsInc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Foghorn TherapeuticsInc has no effect on the direction of Molecular Partners i.e., Molecular Partners and Foghorn TherapeuticsInc go up and down completely randomly.
Pair Corralation between Molecular Partners and Foghorn TherapeuticsInc
Given the investment horizon of 90 days Molecular Partners AG is expected to generate 0.91 times more return on investment than Foghorn TherapeuticsInc. However, Molecular Partners AG is 1.09 times less risky than Foghorn TherapeuticsInc. It trades about -0.01 of its potential returns per unit of risk. Foghorn TherapeuticsInc is currently generating about -0.08 per unit of risk. If you would invest 390.00 in Molecular Partners AG on February 2, 2024 and sell it today you would lose (13.00) from holding Molecular Partners AG or give up 3.33% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Molecular Partners AG vs. Foghorn TherapeuticsInc
Performance |
Timeline |
Molecular Partners |
Foghorn TherapeuticsInc |
Molecular Partners and Foghorn TherapeuticsInc Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Molecular Partners and Foghorn TherapeuticsInc
The main advantage of trading using opposite Molecular Partners and Foghorn TherapeuticsInc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Molecular Partners position performs unexpectedly, Foghorn TherapeuticsInc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Foghorn TherapeuticsInc will offset losses from the drop in Foghorn TherapeuticsInc's long position.Molecular Partners vs. Pulmatrix | Molecular Partners vs. Adial Pharmaceuticals | Molecular Partners vs. Jaguar Animal Health | Molecular Partners vs. Acasti Pharma |
Foghorn TherapeuticsInc vs. Pulmatrix | Foghorn TherapeuticsInc vs. Adial Pharmaceuticals | Foghorn TherapeuticsInc vs. Jaguar Animal Health | Foghorn TherapeuticsInc vs. Acasti Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Global Correlations Find global opportunities by holding instruments from different markets |